Two Stocks To Ponder On: CVS Health Corporation (NYSE:CVS) ; Bausch Health Companies Inc. (NYSE:BHC)

CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) closed at $65.55 on the last trading session with an decrease of -0.74%, whereas, it previously closed at $66.04. The company has a market capitalization of $83.2 Billion. The company traded shares of 15.47 Million on the trading day while its three month average volume stands at 9.58 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of CVS Health Corporation (NYSE:CVS) produced diluted EPS of 1.56. The EPS estimate for next year as estimated by analysts is at 7.58 while EPS for next quarter is estimated at 2.04. Earnings per Share growth for this year is reported at 1.8, while the analysts estimated the EPS growth for next year at 7.58% and Earnings growth for next 5 years stands at 12.58% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 10.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of CVS Health Corporation (NYSE:CVS) is at 41.94 while the forward p/e is at 8.65. The P/S or Price to Sales ratio of CVS Health Corporation (NYSE:CVS) stands at 0.44 and Price to Book or P/B for the most recent quarter stands at 1.83. The Price to Free Cash Flow ratio or P/FCF is reported at 36.91. The quick ratio and the current ratio of CVS Health Corporation (NYSE:CVS) are reported at 1.9 and 2.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for CVS Health Corporation (NYSE:CVS) stands at 2.5, 8.3 and 9.9 respectively

The trailing twelve month Revenue of CVS Health Corporation (NYSE:CVS) is reported at 188.06 Billion with income of 1.6 Billion. The outstanding shares of CVS Health Corporation (NYSE:CVS) are 1.27 Billion. The institutional Ownership of the shares of 69.7 stands at 0.80%, this figure is increased 0.31 in the last six months. The insider ownership for the shares of CVS Health Corporation (NYSE:CVS) is ticked at 0.1%, the figure is plummeted -16.65% in the last six months.

Some other important financial aspects to be discussed here for CVS Health Corporation (NYSE:CVS) is the Mean Target Price estimated by the analysts which stands at 92.41. The 52 week high of CVS Health Corporation (NYSE:CVS) is placed at 83.88 and 52 week low is standing at 60.14.

Performance wise the shares of CVS Health Corporation (NYSE:CVS) rose up 0.49% for the week, it also fell -10.62% for the monthly performance, while for the quarter it went up -17.54%. The shares decrease -2.6% for the half year and flew up for the Year-To-Date performance. The shares of CVS Health Corporation (NYSE:CVS) shrinked -15.63% for the yearly performance.

Bausch Health Companies Inc. (NYSE:BHC)

Bausch Health Companies Inc. (NYSE:BHC) closed at $22.53 on the last trading session with an decrease of -3.43%, whereas, it previously closed at $23.33. The company has a market capitalization of $7.92 Billion. The company traded shares of 5.42 Million on the trading day while its three month average volume stands at 4.95 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Bausch Health Companies Inc. (NYSE:BHC) produced diluted EPS of -12.14. The EPS estimate for next year as estimated by analysts is at 3.8 while EPS for next quarter is estimated at 0.84. Earnings per Share growth for this year is reported at 158.6, while the analysts estimated the EPS growth for next year at 3.8% and Earnings growth for next 5 years stands at 7.05% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 66.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Bausch Health Companies Inc. (NYSE:BHC) is at 0 while the forward p/e is at 5.94. The P/S or Price to Sales ratio of Bausch Health Companies Inc. (NYSE:BHC) stands at 0.94 and Price to Book or P/B for the most recent quarter stands at 2.51. The Price to Free Cash Flow ratio or P/FCF is reported at 4.84. The quick ratio and the current ratio of Bausch Health Companies Inc. (NYSE:BHC) are reported at 0.9 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Bausch Health Companies Inc. (NYSE:BHC) stands at -9.3, -77.9 and 9.8 respectively

The trailing twelve month Revenue of Bausch Health Companies Inc. (NYSE:BHC) is reported at 8.42 Billion with income of -4266000000. The outstanding shares of Bausch Health Companies Inc. (NYSE:BHC) are 351.5 Million. The institutional Ownership of the shares of 66.8 stands at 0.80%, this figure is increased 19.95 in the last six months. The insider ownership for the shares of Bausch Health Companies Inc. (NYSE:BHC) is ticked at 2.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Bausch Health Companies Inc. (NYSE:BHC) is the Mean Target Price estimated by the analysts which stands at 29.86. The 52 week high of Bausch Health Companies Inc. (NYSE:BHC) is placed at 28.45 and 52 week low is standing at 14.44.

Performance wise the shares of Bausch Health Companies Inc. (NYSE:BHC) rose up 9.96% for the week, it also fell -1.4% for the monthly performance, while for the quarter it went up -12.33%. The shares decrease -5.18% for the half year and flew up for the Year-To-Date performance. The shares of Bausch Health Companies Inc. (NYSE:BHC) shrinked -5.61% for the yearly performance.